# Efficacy and Safety of Lima Association in the Control of Type II Diabetes Mellitus.

> **NCT03766750** · PHASE3 · WITHDRAWN · sponsor: **EMS**

## Conditions studied

- Type2 Diabetes Mellitus

## Interventions

- **DRUG:** LIMA association
- **DRUG:** Tradjenta
- **DRUG:** Forxiga

## Key facts

- **NCT ID:** NCT03766750
- **Lead sponsor:** EMS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-12
- **Primary completion:** 2023-10
- **Final completion:** 2023-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2022-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03766750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03766750, "Efficacy and Safety of Lima Association in the Control of Type II Diabetes Mellitus.". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03766750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*